T1	Participants 69 126	previously treated patients with metastatic breast cancer
T2	Participants 129 276	Three hundred twenty-five women with metastatic adenocarcinoma of the breast who had failed one prior chemotherapeutic regimen for advanced disease
T3	Participants 2032 2056	metastatic breast cancer
